ArticleBMC gastroenterology2025
Building a risk prediction model for anastomotic leakage postoperative low rectal cancer based on Lasso-Logistic regression.
Article in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Prognostic value of preoperative anorectal manometry parameters for anastomotic leakage after sphincter-preserving surgery for rectal cancer.International journal of colorectal disease · 2026Article
- A risk prediction model for overall and Grade C anastomotic leakage after rectal cancer surgery.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo build a nomogram model for predicting the risk of anastomotic leakage (AL) postoperative low rectal cancer based on Lasso-Logistic regression.
methodsA total of 482 patients with rectal cancer who underwent low rectal cancer surgery in our hospital from June 2017 to May 2023 were selected as the training set, and 127 patients with rectal cancer who underwent low rectal cancer surgery in our hospital from June 2023 to April 2025 were selected as the validation set. According to whether AL occurred postoperative, the patients in the training set were divided into AL group (n = 54) and N-AL group (n = 428). The data of each group were collected, and the influencing factors of AL in patients postoperative with rectal cancer in the training set were analyzed by Lasso-Logistic regression model. H-L goodness-of-fit test, ROC curve and calibration curve were used to analyze the discrimination and consistency of the model. The nomogram model was validated using the validation set. The DCA curve was used to evaluate the clinical utility of the model.
resultsIn the training set, the AL group had a higher proportion of patients with tumor stage ≥ T3 and longer operation times compared to the N-AL group; additionally, fewer AL patients had a protective stoma, and the tumor was located a shorter distance from the tumor to the anal verge than in the N-AL group. (P < 0.05). Lasso-Logistic regression analysis showed that when the penalty coefficient λ = 0.02735463, the model demonstrated good performance, gender (OR = 3.107), NRS2002 score (OR = 8.619), protective stoma (OR = 0.297), distance from tumor to anal verge (OR = 0.284), operation time (OR = 1.033) were the influencing factors of postoperative AL in low rectal cancer (P < 0.05). The 5 influencing factors were introduced into R software to establish a nomogram model for the risk of postoperative AL in low rectal cancer. The area under the ROC curve was 0.940. H-L goodness of fit test showed that there was no significant difference between the predicted value of the model and the actual observed value (χ
conclusionGender, NRS2002 rating, diverting ostomy, distance from tumor to anal margin, and operation time are all influencing factors of postoperative AL in low rectal cancer. The nomogram prediction model based on Lasso-Logistic regression has high consistency, discrimination and clinical application value.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.